APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nifedipine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017030321 December 2025181 pages

Choose your research edition.

Industry ResearchNifedipine Injection Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Injection Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Nifedipine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Injection Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nifedipine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nifedipine Injection include Teva, Medcalo, Mylan, Pfizer, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Bayer, Pharmaoffer and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nifedipine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nifedipine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nifedipine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nifedipine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Nifedipine Injection Segment by Company

Teva

Medcalo

Mylan

Pfizer

Cisen Pharmaceutical

Wuhan Binhu Shuanghe Pharmaceutical

Bayer

Pharmaoffer

AdvaCare

Nifedipine Injection Segment by Type

10mg/2ml

20mg/2ml

Nifedipine Injection Segment by Application

Hypertension

Angina (Chest Pain)

Nifedipine Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nifedipine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nifedipine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nifedipine Injection Industry Trends Table 2. Nifedipine Injection Industry Drivers Table 3. Nifedipine Injection Industry Opportunities and Challenges Table 4. Nifedipine Injection Industry Restraints Table 5. Global Nifedipine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nifedipine Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nifedipine Injection Sales by Manufacturers (L) & (2021-2026) Table 8. Global Nifedipine Injection Sales Market Share by Manufacturers Table 9. Global Nifedipine Injection Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Nifedipine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nifedipine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nifedipine Injection Manufacturers, Product Type & Application Table 13. Global Nifedipine Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nifedipine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg/2ml Table 17. Major Manufacturers of 20mg/2ml Table 18. Global Nifedipine Injection Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global Nifedipine Injection Sales by Type (2021-2026) & (L) Table 20. Global Nifedipine Injection Sales by Type (2027-2032) & (L) Table 21. Global Nifedipine Injection Sales Market Share by Type (2021-2026) Table 22. Global Nifedipine Injection Sales Market Share by Type (2027-2032) Table 23. Global Nifedipine Injection Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global Nifedipine Injection Revenue by Type (2021-2026) & (L) Table 25. Global Nifedipine Injection Revenue by Type (2027-2032) & (L) Table 26. Global Nifedipine Injection Revenue Market Share by Type (2021-2026) Table 27. Global Nifedipine Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hypertension Table 29. Major Manufacturers of Angina (Chest Pain) Table 30. Global Nifedipine Injection Sales by Application 2021 VS 2025 VS 2032 (L) Table 31. Global Nifedipine Injection Sales by Application (2021-2026) & (L) Table 32. Global Nifedipine Injection Sales by Application (2027-2032) & (L) Table 33. Global Nifedipine Injection Sales Market Share by Application (2021-2026) Table 34. Global Nifedipine Injection Sales Market Share by Application (2027-2032) Table 35. Global Nifedipine Injection Revenue by Application 2021 VS 2025 VS 2032 (L) Table 36. Global Nifedipine Injection Revenue by Application (2021-2026) & (L) Table 37. Global Nifedipine Injection Revenue by Application (2027-2032) & (L) Table 38. Global Nifedipine Injection Revenue Market Share by Application (2021-2026) Table 39. Global Nifedipine Injection Revenue Market Share by Application (2027-2032) Table 40. Global Nifedipine Injection Sales by Region: 2021 VS 2025 VS 2032 (L) Table 41. Global Nifedipine Injection Sales by Region (2021-2026) & (L) Table 42. Global Nifedipine Injection Sales Market Share by Region (2021-2026) Table 43. Global Nifedipine Injection Sales Forecasted by Region (2027-2032) & (L) Table 44. Global Nifedipine Injection Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 46. North America Nifedipine Injection Sales by Country (2021-2026) & (L) Table 47. North America Nifedipine Injection Sales by Country (2027-2032) & (L) Table 48. Europe Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 49. Europe Nifedipine Injection Sales by Country (2021-2026) & (L) Table 50. Europe Nifedipine Injection Sales by Country (2027-2032) & (L) Table 51. Asia Pacific Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 52. Asia Pacific Nifedipine Injection Sales by Country (2021-2026) & (L) Table 53. Asia Pacific Nifedipine Injection Sales by Country (2027-2032) & (L) Table 54. South America, Middle East and Africa Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 55. South America, Middle East and Africa Nifedipine Injection Sales by Country (2021-2026) & (L) Table 56. South America, Middle East and Africa Nifedipine Injection Sales by Country (2027-2032) & (L) Table 57. Global Nifedipine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nifedipine Injection Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Nifedipine Injection Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Nifedipine Injection Revenue Market Share by Region (2021-2026) Table 61. Global Nifedipine Injection Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Nifedipine Injection Product Portfolio Table 66. Teva Recent Development Table 67. Medcalo Company Information Table 68. Medcalo Business Overview Table 69. Medcalo Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Medcalo Nifedipine Injection Product Portfolio Table 71. Medcalo Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Mylan Nifedipine Injection Product Portfolio Table 76. Mylan Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pfizer Nifedipine Injection Product Portfolio Table 81. Pfizer Recent Development Table 82. Cisen Pharmaceutical Company Information Table 83. Cisen Pharmaceutical Business Overview Table 84. Cisen Pharmaceutical Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Cisen Pharmaceutical Nifedipine Injection Product Portfolio Table 86. Cisen Pharmaceutical Recent Development Table 87. Wuhan Binhu Shuanghe Pharmaceutical Company Information Table 88. Wuhan Binhu Shuanghe Pharmaceutical Business Overview Table 89. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio Table 91. Wuhan Binhu Shuanghe Pharmaceutical Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Bayer Nifedipine Injection Product Portfolio Table 96. Bayer Recent Development Table 97. Pharmaoffer Company Information Table 98. Pharmaoffer Business Overview Table 99. Pharmaoffer Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Pharmaoffer Nifedipine Injection Product Portfolio Table 101. Pharmaoffer Recent Development Table 102. AdvaCare Company Information Table 103. AdvaCare Business Overview Table 104. AdvaCare Nifedipine Injection Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. AdvaCare Nifedipine Injection Product Portfolio Table 106. AdvaCare Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Nifedipine Injection Distributors List Table 110. Nifedipine Injection Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Nifedipine Injection Product Image Figure 2. Global Nifedipine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Injection Sales (2021-2032) & (L) Figure 5. Global Nifedipine Injection Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Nifedipine Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg/2ml Image Figure 9. 20mg/2ml Image Figure 10. Global Nifedipine Injection Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global Nifedipine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Nifedipine Injection Sales Market Share by Type (2021-2032) Figure 13. Global Nifedipine Injection Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Nifedipine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Nifedipine Injection Revenue Market Share by Type (2021-2032) Figure 16. Hypertension Image Figure 17. Angina (Chest Pain) Image Figure 18. Global Nifedipine Injection Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 19. Global Nifedipine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Nifedipine Injection Sales Market Share by Application (2021-2032) Figure 21. Global Nifedipine Injection Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 22. Global Nifedipine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Nifedipine Injection Revenue Market Share by Application (2021-2032) Figure 24. North America Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 25. North America Nifedipine Injection Sales Market Share by Country (2021-2032) Figure 26. U.S. Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 27. Canada Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 28. Mexico Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 29. Europe Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe Nifedipine Injection Sales Market Share by Country (2021-2032) Figure 31. Germany Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 32. France Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 33. U.K. Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 34. Italy Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 35. Netherlands Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 36. Asia Pacific Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific Nifedipine Injection Sales Market Share by Country (2021-2032) Figure 38. China Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 39. Japan Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 40. South Korea Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 41. Southeast Asia Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 42. India Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 43. Australia Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 44. South America, Middle East and Africa Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa Nifedipine Injection Sales Market Share by Country (2021-2032) Figure 46. Brazil Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 47. South Africa Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 48. Saudi Arabia Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 49. Turkey Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 50. Argentina Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 51. UAE Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 52. Egypt Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 53. Chile Nifedipine Injection Sales and Growth Rate (2021-2032) & (L) Figure 54. Global Nifedipine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Nifedipine Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Nifedipine Injection Revenue (2021-2032) & (US$ Million) Figure 57. North America Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Nifedipine Injection Revenue (2021-2032) & (US$ Million) Figure 59. Europe Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Nifedipine Injection Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Nifedipine Injection Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Nifedipine Injection Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Nifedipine Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/2ml
  • 20mg/2ml
Applications
  • Hypertension
  • Angina (Chest Pain)
Companies covered
  • Teva
  • Medcalo
  • Mylan
  • Pfizer
  • Cisen Pharmaceutical
  • Wuhan Binhu Shuanghe Pharmaceutical
  • Bayer
  • Pharmaoffer
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nifedipine Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nifedipine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nifedipine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nifedipine Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nifedipine Injection Market Dynamics
  1. 2.1 Nifedipine Injection Industry Trends
  2. 2.2 Nifedipine Injection Industry Drivers
  3. 2.3 Nifedipine Injection Industry Opportunities and Challenges
  4. 2.4 Nifedipine Injection Industry Restraints
3 Nifedipine Injection Market by Manufacturers
  1. 3.1 Global Nifedipine Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nifedipine Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nifedipine Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nifedipine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nifedipine Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nifedipine Injection Manufacturers, Product Type & Application
  7. 3.7 Global Nifedipine Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nifedipine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nifedipine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nifedipine Injection Tier 1, Tier 2, and Tier 3
4 Nifedipine Injection Market by Type
  1. 4.1 Nifedipine Injection Type Introduction
  2. 4.1.1 10mg/2ml
  3. 4.1.2 20mg/2ml
  4. 4.2 Global Nifedipine Injection Sales by Type
  5. 4.2.1 Global Nifedipine Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nifedipine Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Nifedipine Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Nifedipine Injection Revenue by Type
  9. 4.3.1 Global Nifedipine Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nifedipine Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Nifedipine Injection Revenue Market Share by Type (2021-2032)
5 Nifedipine Injection Market by Application
  1. 5.1 Nifedipine Injection Application Introduction
  2. 5.1.1 Hypertension
  3. 5.1.2 Angina (Chest Pain)
  4. 5.2 Global Nifedipine Injection Sales by Application
  5. 5.2.1 Global Nifedipine Injection Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nifedipine Injection Sales by Application (2021-2032)
  7. 5.2.3 Global Nifedipine Injection Sales Market Share by Application (2021-2032)
  8. 5.3 Global Nifedipine Injection Revenue by Application
  9. 5.3.1 Global Nifedipine Injection Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nifedipine Injection Revenue by Application (2021-2032)
  11. 5.3.3 Global Nifedipine Injection Revenue Market Share by Application (2021-2032)
6 Global Nifedipine Injection Sales by Region
  1. 6.1 Global Nifedipine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nifedipine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Nifedipine Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Nifedipine Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nifedipine Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nifedipine Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nifedipine Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nifedipine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nifedipine Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nifedipine Injection Revenue by Region
  1. 7.1 Global Nifedipine Injection Revenue by Region
  2. 7.1.1 Global Nifedipine Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nifedipine Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Nifedipine Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Nifedipine Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nifedipine Injection Revenue (2021-2032)
  8. 7.2.2 North America Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nifedipine Injection Revenue (2021-2032)
  11. 7.3.2 Europe Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nifedipine Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nifedipine Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nifedipine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Nifedipine Injection Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Medcalo
  8. 8.2.1 Medcalo Company Information
  9. 8.2.2 Medcalo Business Overview
  10. 8.2.3 Medcalo Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medcalo Nifedipine Injection Product Portfolio
  12. 8.2.5 Medcalo Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Nifedipine Injection Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Nifedipine Injection Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Cisen Pharmaceutical
  26. 8.5.1 Cisen Pharmaceutical Company Information
  27. 8.5.2 Cisen Pharmaceutical Business Overview
  28. 8.5.3 Cisen Pharmaceutical Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio
  30. 8.5.5 Cisen Pharmaceutical Recent Developments
  31. 8.6 Wuhan Binhu Shuanghe Pharmaceutical
  32. 8.6.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information
  33. 8.6.2 Wuhan Binhu Shuanghe Pharmaceutical Business Overview
  34. 8.6.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio
  36. 8.6.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Nifedipine Injection Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Pharmaoffer
  44. 8.8.1 Pharmaoffer Company Information
  45. 8.8.2 Pharmaoffer Business Overview
  46. 8.8.3 Pharmaoffer Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pharmaoffer Nifedipine Injection Product Portfolio
  48. 8.8.5 Pharmaoffer Recent Developments
  49. 8.9 AdvaCare
  50. 8.9.1 AdvaCare Company Information
  51. 8.9.2 AdvaCare Business Overview
  52. 8.9.3 AdvaCare Nifedipine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AdvaCare Nifedipine Injection Product Portfolio
  54. 8.9.5 AdvaCare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nifedipine Injection Value Chain Analysis
  2. 9.1.1 Nifedipine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nifedipine Injection Production Mode & Process
  6. 9.2 Nifedipine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nifedipine Injection Distributors
  9. 9.2.3 Nifedipine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst